GSK plc

Health

Healthy Returns: Weight loss drug Wegovy could face Medicare price negotiations next

Boxes of Ozempic and Wegovy made by Novo Nordisk are seen at a pharmacy in London, Britain March 8, 2024. …

Read More »
Health

Moderna to cut $1.1 billion in costs and launch 10 new products by 2027 as it charts post-Covid future

Moderna headquarters, exterior view, Cambridge, Massachusetts, USA.  Plexi Images | GHI | UCG | Universal Images Group | Getty Images Moderna…

Read More »
Health

Moderna stock falls 20% as it slashes guidance on low EU sales, tough U.S. vaccine market

The Moderna Inc. headquarters in Cambridge, Massachusetts, US, on Tuesday, March 26, 2024.  Adam Glanzman | Bloomberg | Getty Images…

Read More »
Health

Pfizer struggles to claw back faith with Wall Street and its employees as it recovers from the Covid decline

Kena Betancur | Corbis News | Getty Images Pfizer had a “phenomenal” first quarter — and Wall Street took notice,…

Read More »
Health

FDA approves Merck vaccine designed to protect adults from bacteria that can cause pneumonia, serious infections

Zoom In IconArrows pointing outwards Merck’s new pneumococcal vaccine. Courtesy: Merck The Food and Drug Administration on Monday approved Merck‘s…

Read More »
Health

FDA approves GSK’s RSV vaccine for high-risk adults ages 50 to 59, expanding shot’s reach

A view shows GlaxoSmithKline headquarters in London, Britain, January 17, 2022. Hannah Mckay | Reuters The Food and Drug Administration…

Read More »
Health

Pharma giant GSK plunges 9% after U.S. court allows scientific testimony in Zantac lawsuits

Company logo of pharmaceutical company GlaxoSmithKline is seen at their Stevenage facility, Britain October 26, 2020.  Matthew Childs | Reuters…

Read More »
Health

FDA approves Moderna’s RSV vaccine for seniors, the company’s second-ever product

The FDA has approved Moderna’s RSV vaccine for older adults. Courtesy: Moderna The Food and Drug Administration on Friday approved…

Read More »
Health

Moderna says FDA delayed RSV vaccine approval to end of May

Nikos Pekiaridis | Lightrocket | Getty Images Moderna on Friday said the Food and Drug Administration has delayed the approval…

Read More »
Health

Pfizer’s RSV vaccine shows potential to protect high-risk adults ages 18-59, widening possible use

Respiratory syncytial virus – viral vaccine under research Hailshadow | Istock | Getty Images A vaccine from Pfizer showed the…

Read More »
Back to top button